Woodline Partners’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Woodline Partners's ATTO Position: Q3 2026 in Review
Woodline Partners opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 686,746 shares worth $11.8M. The stake represents 0.04% of the portfolio and ranks #531 among its holdings.
35 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Woodline Partners held 686,746 shares of Attovia Therapeutics worth $11.8M as of Q3 2026.
- Attovia Therapeutics was a new Woodline Partners position in Q3 2026.
- Attovia Therapeutics made up 0.04% of Woodline Partners's portfolio in Q3 2026, its #531 holding.
- 35 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.